Orbimed ROF II LLC, 10% Owner at Xtant Medical Holdings, Inc. (XTNT), sold 146,229,184 shares at $0.42 ($61.4M) on 2025-04-10, disclosed to the SEC on 2025-04-14.
Open-market sale of $61.4M XTNT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.42 | 17,109,618 | $7.2M | 11.7% |
| 2 | $0.42 | 17,109,618 | $7.2M | 11.7% |
| 3 | $0.42 | 56,004,974 | $23.5M | 38.3% |
| 4 | $0.42 | 56,004,974 | $23.5M | 38.3% |
| Total | $0.42 avg | 146,229,184 | $61.4M | 100% |